CompletedNCT04978428
Epidiolex in OCD and Related Disorders
Official study title
An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept Study
Medication studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Chicago, United StatesSee all locations and recruitment
- Activities
- Medication described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: April 14, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 4
- Sponsor
- University of Chicago
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04978428
Recruitment & locations
CompletedChicago
Questions about this study
Who is behind this study?
The study sponsor is University of Chicago, a university.
Did this study involve medication?
Yes. The study involved medication, including Cannabidiol.
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01404208
2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
United States
CompletedNCT05624528
A study of Tolcapone in OCD
United States
CompletedNCT01674361
Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in people with OCD (OCD)
United States, Canada